CASE DISCUSSION
Dapagliflozin in patients with Chronic Kidney Disease
Presented India by Dr. Satyanarayana GarreViews
15,456
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT-2) inhibitor that has shown promise in the management of Chronic Kidney Disease (CKD) in patients with type 2 diabetes. Dapagliflozin has demonstrated efficacy in reducing the progression of CKD in individuals with type 2 diabetes by...
Case Summary
- The speaker discusses SGLT2 inhibitors, a relatively new class of anti-diabetic medications introduced around 2018-2019, highlighting their significant impact on managing diabetic kidney disease (DKD) and chronic kidney disease (CKD). They emphasize the breakthrough nature of these drugs, especially considering the limited concrete options available for handling these conditions in previous decades.
Speaker Profile
Dr. Satyanarayana Garre
MBBS, MD, DNB( Nephrology) Apollo hospitals HyderabadDr. Satyanarayana Garre is a Nephrologist associated with Apollo Hospitals with expertise in kidney diseases and renal care.
He holds MBBS, MD, and DNB in Nephrology, reflecting advanced training in internal medicine and nephrology.
His clinical interests include chronic kidney disease, dialysis management, hypertension, electrolyte disorders, and preventive renal healthcare.
He is committed to providing evidence-based and patient-centered nephrology care using advanced diagnostic and treatment approaches.
Through his clinical practice, he contributes to improving kidney health outcomes and comprehensive renal care services.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.